Dicot Pharma's Board to Launch SEK210 Million Rights Issue
11 maj, 09:48
03:48 AM EDT, 05/11/2026 (MT Newswires) -- Dicot Pharma's (DICOT.ST) board decided to launch a 210 million-krona rights issue of 1,236,518,456 new shares, according to a May 8 release.
As part of the offer, subscription undertakings and guarantee commitments amounted to up to 80%, or 168 million kronor. The existing shareholders, board members, and management have committed about 17.7 million kronor, while Schonfeld Global Master Fund, Anavio Capital Partners, and Vator Securities provided guarantees worth 150.5 million kronor, according to a May 8 release.
The Swedish pharmaceutical company will use the proceeds to fund its planned phase 2b study for erectile dysfunction drug candidate LIB-01.
Ämnen i artikeln
Dicot Pharma's Board to Launch SEK210 Million Rights Issue
11 maj, 09:48
03:48 AM EDT, 05/11/2026 (MT Newswires) -- Dicot Pharma's (DICOT.ST) board decided to launch a 210 million-krona rights issue of 1,236,518,456 new shares, according to a May 8 release.
As part of the offer, subscription undertakings and guarantee commitments amounted to up to 80%, or 168 million kronor. The existing shareholders, board members, and management have committed about 17.7 million kronor, while Schonfeld Global Master Fund, Anavio Capital Partners, and Vator Securities provided guarantees worth 150.5 million kronor, according to a May 8 release.
The Swedish pharmaceutical company will use the proceeds to fund its planned phase 2b study for erectile dysfunction drug candidate LIB-01.
Ämnen i artikeln
Analys
Regeringens krispaket
Analys
Regeringens krispaket
Marknadsöversikt
1 DAG %
Senast
1 mån
